DIVD Altrius Global Dividend ETF
ETF on NASDAQ (US) · Actively managed · Listing
Changes appear once four weeks of holdings are on file.
Largest holding: AXA SA, 11,586 units ($590K).
| Current positions Top 10 | % of book |
|---|---|
| AXA SA AXAHY $590K | 2.2% |
| BAE Systems PLC BAESY $590K | 2.2% |
| BP PLC BP $590K | 2.2% |
| BNP Paribas SA BNPQY $590K | 2.2% |
| Banco Bilbao Vizcaya Argentaria S.A. BBVA $590K | 2.2% |
| Capgemini SE CGEMY $590K | 2.2% |
| DHL AG DHLGY $590K | 2.2% |
| GSK plc GSK $590K | 2.2% |
| Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen MURGY $590K | 2.2% |
| Nestle SA NSRGY $590K | 2.2% |
Slices are % of holdings value.
| Sectors | % of long value |
|---|---|
| Healthcare | 18.2% |
| Financial Services | 13.9% |
| Consumer Defensive | 13.8% |
| Energy | 6.7% |
| Consumer Cyclical | 5.7% |
| Basic Materials | 5.7% |
| Industrials | 3.6% |
| Technology | 3.4% |
| Other (2) | 2.4% |
| Unclassified | 26.7% |
| Industries | % of long value |
|---|---|
| Drug Manufacturers - General | 13.4% |
| Banks - Diversified | 9.1% |
| Oil & Gas Integrated | 6.7% |
| Tobacco | 4.5% |
| Packaged Foods | 3.6% |
| Specialty Chemicals | 3.5% |
| Beverages - Brewers | 3.3% |
| Other (20) | 29.2% |
| Unclassified | 26.7% |
Source: the fund's own published holdings, the portfolio of Nov 18, 2026 (altriusfunds.com). Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Dec 1, 2025.
The Altrius Global Dividend ETF (the "Fund") seeks long-term capital growth of capital and income.
Principal investment strategies
Altrius Global Dividend ETF (the "Fund") is an actively managed exchange-traded fund ("ETF") that is designed to provide capital appreciation and income by identifying dividend paying companies with attractive valuations and other financial characteristics. Altrius Capital Management, Inc. (the "Sub-Adviser") is responsible for the Fund's security investment recommendations. The Sub-Adviser acts as a non-discretionary sub-adviser and provides its investment recommendations to Empowered Funds, LLC dba EA Advisers (the "Adviser"). In turn, the Adviser makes the corresponding trades. To pursue its objective, the Fund will invest at least 90% of its net assets, plus the amount of any borrowings for investment purposes, in dividend-paying equity securities. The principal type of equity security in which the Fund will invest is common stock. The Fund invests primarily in the securities of issuers that the Sub-Adviser 1 believes to have attractive valuations, potential for long-term growth, sustainable dividends, and other attractive financial characteristics. The Fund's portfolio is composed of approximately 45 to 100 stocks (including American Depositary Receipts or "ADRs"). Under normal market conditions, at least 30% of the Fund's assets will be invested outside the United States. The majority of the stocks normally will have market capitalizations greater than $1 billion at the time of purchase by the Fund. The Fund intends to diversify its investments across different countries, and the percentage of the Fund's assets invested in particular countries or regions will change from time to time based on the Sub-Adviser's judgment (as described below). The Fund intends to invest in the securities of companies located in developed countries and, to a lesser extent, those located in emerging markets. The Fund may consider investments in companies in any of the world's developed stock markets, such as the United States or the United Kingdom and stock markets in the European Union or Asia Pacific. The Fund may invest up to 20% of the Fund's total assets in emerging market companies, however it is expected that emerging market investments will generally be less than 5% of the portfolio. The Sub-Adviser employs the following three-step approach starting with a global macro (top down) approach, further refined by bottom-up value investment analysis, and finalized by the selection of companies that have been paying and show a commitment, to increasing their dividend. Step 1: The Sub-Adviser first considers its global macro views and identifies sectors consistent with those views based on positive demographics and durable businesses (as defined by the issuer's market capitalization) with an emphasis on demand changes. Positive demographics include developed, stabilized and growing economies, which are evaluated based on national GDP growth. Sectors are selected based on the Sub-Adviser's global macro views of the sectors that it believes will benefit from global macro conditions over a minimum of the next five years. Once the global macro sectors are identified, individual securities are evaluated based on their total return (projected dividends plus anticipated capital appreciation), and then evaluated through fundamental analysis. Step 2: From a total return perspective, the Sub-Adviser identifies all sources of a company's returns, including dividends, which are often overlooked by investors, dividend growth and expected capital appreciation. The Sub-Adviser seeks to identify companies that pay higher than average dividends as compared to the S&P 500 Index or MSCI EAFE Index, and companies that have generally increased their dividends over the last 15 years. The Sub-Adviser considers a company's balance sheet and cashflow statements to determine how a company has historically grown earnings and how the earnings growth has impacted future dividend payment.
Management and Contact
- Adviser
- Empowered Funds, LLC
- Sub-adviser
- Altrius Capital Management, Inc.
- Portfolio managers
-
James M. Russo, Founder and Chief Investment Strategist of the Sub-Adviser, Anu Prabhu, CFA®, Portfolio Manager of the Sub-Adviser, and Brady Gingrich, Portfolio Manager, are jointly and primarily responsible for the day-to-day management of the Fund.
Mr. Russo has served as a portfolio manager of the Fund since September 2022;
Ms. Prabhu has served as a portfolio manager of the Fund since May 2023;
Mr. Gingrich has served as a portfolio manager of the Fund since November 2025.
Messrs. Russo and Gingrich and Ms. Prabhu provide their recommendations to Messrs. Richard Shaner and Wm. Joshua Russell, Portfolio Managers of the Adviser.
Mr. Shaner has served as a portfolio manager of the Fund since September 2022;
Mr. Russell has served as portfolio manager of the Fund since January 2023.
- Website
- altriusfunds.com
Track Record as of Nov 18, 2026
Standardized returns published on the fund's website. Returns in percent; periods over a year are annualized.
| 1 Month | 3 Months | 6 Months | YTD | 1 Year | 3 Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| NAV | -4.84% | 0.63% | 5.27% | 12.70% | 18.84% | 16.75% | 18.22% |
| MKT | -4.74% | 0.77% | 5.57% | 13.00% | 19.03% | 16.81% | 18.26% |
Track Record as of Jul 31, 2025
Average annual total returns from the summary prospectus. Returns in percent; periods over a year are annualized.
| 1 Year | Since Inception | |
|---|---|---|
| 70% Solactive GBS United States 1000 Index, 30% Solactive GBS Developed Markets ex North America Large & Mid Cap Index (reflects | 17.82% | 22.75% |
| Solactive GBS Global Markets All Cap Index (reflects no deduction for fees or expenses) | 16.75% | 21.60% |
| Return Before Taxes | 2.75% | 15.07% |
| Return After Taxes on Distributions | 2.12% | 14.39% |
| Return After Taxes on Distributions and Sale of Shares | 2.39% | 11.85% |
Holdings as of Nov 18, 2026
The full portfolio the fund publishes every business day on its website (altriusfunds.com). Every line is listed: holdings we could identify link to their page, the rest (cash, options, swaps, private shares, securities we do not carry) are shown as the fund prints them. Short positions are negative. Change is the share count against Nov 17, 2026.
66 lines, 51 linked, weights sum to 99.98% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
|
Vinci SA
|
VCISY 927320101 | Equity | 18,781 | +1,946 | 2.17% | $ 590K |
| TotalEnergies SE | TTE F92124100 | Equity | 6,534 | +52 | 2.17% | $ 590K |
| BP PLC | BP 055622104 | Equity | 13,113 | +423 | 2.16% | $ 590K |
| Banco Bilbao Vizcaya Argentaria SA | BBVA 05946K101 | Equity | 23,088 | +2,927 | 2.16% | $ 590K |
|
Capgemini SE
|
CGEMY 13961R100 | Equity | 22,151 | −1,342 | 2.16% | $ 590K |
|
Publicis Groupe SA
|
PUBGY 74463M106 | Equity | 20,988 | +859 | 2.16% | $ 590K |
| Royal Bank of Canada | RY 780087102 | Equity | 2,996 | +290 | 2.16% | $ 590K |
|
AXA SA
|
AXAHY 054536107 | Equity | 11,586 | +528 | 2.15% | $ 590K |
|
BAE Systems PLC
|
BAESY 05523R107 | Equity | 5,983 | +610 | 2.15% | $ 590K |
|
BNP Paribas SA
|
BNPQY 05565A202 | Equity | 11,340 | +1,800 | 2.15% | $ 590K |
|
DHL AG
|
DHLGY 25157Y202 | Equity | 17,752 | +145 | 2.15% | $ 590K |
| GSK PLC | GSK 37733W204 | Equity | 11,910 | +830 | 2.15% | $ 590K |
|
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen
|
MURGY 626188106 | Equity | 45,808 | −3,065 | 2.15% | $ 590K |
|
Nestle SA
|
NSRGY 641069406 | Equity | 5,688 | −101 | 2.15% | $ 590K |
| Novartis AG | NVS 66987V109 | Equity | 3,690 | +82 | 2.15% | $ 590K |
|
Reckitt Benckiser Group PLC
|
RBGLY 756255303 | Equity | 38,625 | −3,931 | 2.15% | $ 590K |
|
Roche Holding AG
|
RHHBY 771195104 | Equity | 9,711 | −753 | 2.15% | $ 590K |
| Sanofi SA | SNY 80105N105 | Equity | 12,312 | −676 | 2.15% | $ 590K |
|
Siemens AG
|
SIEGY 826197501 | Equity | 3,954 | +252 | 2.15% | $ 590K |
| Toyota Motor Corp | TM 892331307 | Equity | 2,757 | −432 | 2.15% | $ 590K |
| AstraZeneca PLC | AZN G0593M107 | Equity | 3,215 | −363 | 2.15% | $ 590K |
| NXP Semiconductors NV | NXPI N6596X109 | Equity | 2,325 | −296 | 2.15% | $ 590K |
| Ambev SA | ABEV 02319V103 | Equity | 215,851 | +16,191 | 2.14% | $ 580K |
| British American Tobacco PLC | BTI 110448107 | Equity | 9,856 | −419 | 2.14% | $ 580K |
| LyondellBasell Industries NV | LYB N53745100 | Equity | 9,628 | +611 | 2.14% | $ 580K |
| Bank of America Corp | BAC 060505104 | Equity | 6,681 | +1,517 | 1.21% | $ 330K |
| Citigroup Inc | C 172967424 | Equity | 2,759 | +378 | 1.21% | $ 330K |
| ExxonMobil Holdings Corp | XOM 30233Q108 | Equity | 1,966 | −20 | 1.21% | $ 330K |
| Franklin Templeton Inc | BEN 354613101 | Equity | 9,595 | −195 | 1.21% | $ 330K |
| Gilead Sciences Inc | GILD 375558103 | Equity | 1,931 | −485 | 1.21% | $ 330K |
| JPMORGAN CHASE & CO. | JPM 46625H100 | Equity | 997 | +93 | 1.21% | $ 330K |
| Lockheed Martin Corp | LMT 539830109 | Equity | 557 | +6 | 1.21% | $ 330K |
| State Street Corp | STT 857477103 | Equity | 1,976 | +280 | 1.21% | $ 330K |
| AbbVie Inc | ABBV 00287Y109 | Equity | 1,122 | −94 | 1.20% | $ 330K |
| BXP Inc | BXP 101121101 | Equity | 5,199 | +594 | 1.20% | $ 330K |
| Coca-Cola Co/The | KO 191216100 | Equity | 3,315 | −538 | 1.20% | $ 330K |
| Constellation Brands Inc | STZ 21036P108 | Equity | 2,272 | −152 | 1.20% | $ 330K |
| Huntington Bancshares Inc/OH | HBAN 446150104 | Equity | 21,451 | +3,313 | 1.20% | $ 330K |
| Johnson & Johnson | JNJ 478160104 | Equity | 1,174 | −34 | 1.20% | $ 330K |
| Kraft Heinz Co/The | KHC 500754106 | Equity | 12,986 | +663 | 1.20% | $ 330K |
| MSC Industrial Direct Co Inc | MSM 553530106 | Equity | 2,822 | +344 | 1.20% | $ 330K |
| Marsh & McLennan Cos Inc | MRSH 571748102 | Equity | 1,584 | −191 | 1.20% | $ 330K |
| McDonald's Corp | MCD 580135101 | Equity | 1,187 | −143 | 1.20% | $ 330K |
| Merck & Co Inc | MRK 58933Y105 | Equity | 2,285 | −119 | 1.20% | $ 330K |
| Pfizer Inc | PFE 717081103 | Equity | 11,540 | −1,009 | 1.20% | $ 330K |
| Procter & Gamble Co/The | PG 742718109 | Equity | 1,902 | −229 | 1.20% | $ 330K |
| Starbucks Corp | SBUX 855244109 | Equity | 3,045 | −25 | 1.20% | $ 330K |
| United Parcel Service Inc | UPS 911312106 | Equity | 2,966 | +228 | 1.20% | $ 330K |
| Abbott Laboratories | ABT 002824100 | Equity | 3,096 | 0 | 1.19% | $ 320K |
| Altria Group Inc | MO 02209S103 | Equity | 4,205 | −131 | 1.19% | $ 330K |
| CME Group Inc | CME 12572Q105 | Equity | 1,046 | −176 | 1.19% | $ 330K |
| Chevron Corp | CVX 166764100 | Equity | 1,520 | −68 | 1.19% | $ 330K |
| Dow Inc | DOW 260557103 | Equity | 10,341 | +261 | 1.19% | $ 320K |
| Eastman Chemical Co | EMN 277432100 | Equity | 5,227 | +599 | 1.19% | $ 330K |
| Gentex Corp | GNTX 371901109 | Equity | 17,264 | +3,903 | 1.19% | $ 320K |
| Paychex Inc | PAYX 704326107 | Equity | 2,853 | 0 | 1.19% | $ 330K |
| PepsiCo Inc | PEP 713448108 | Equity | 2,294 | −25 | 1.19% | $ 330K |
| Philip Morris International Inc | PM 718172109 | Equity | 1,666 | +39 | 1.19% | $ 320K |
| Tyson Foods Inc | TSN 902494103 | Equity | 5,091 | −464 | 1.19% | $ 320K |
| Verizon Communications Inc | VZ 92343V104 | Equity | 7,088 | −8 | 1.19% | $ 330K |
| Medtronic PLC | MDT G5960L103 | Equity | 3,184 | −623 | 1.19% | $ 330K |
| Air Products and Chemicals Inc | APD 009158106 | Equity | 1,053 | 0 | 1.18% | $ 320K |
| UnitedHealth Group Inc | UNH 91324P102 | Equity | 829 | +88 | 1.18% | $ 320K |
|
First American Government Obligations Fund 12/01/2031
|
FGXXX 31846V336 | Money market | 231,842 | 0 | 0.85% | $ 230K |
|
Cash & Other
|
CASH&OTHER | Cash short | -57,825 | −98,859 | -0.21% | $ -60K |
|
EURO
|
EUR CASHEUR | Equity | 4,083 | 0 | 0.02% | $ 0.00 |
Trades Nov 17, 2026 to Nov 18, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
|
BNP Paribas SA
|
BNPQY | Bought | 9,540 | 11,340 | +1,800 | $ 93.651K |
| Toyota Motor Corp | TM | Sold | 3,189 | 2,757 | −432 | $ -92.448K |
| Gilead Sciences Inc | GILD | Sold | 2,416 | 1,931 | −485 | $ -82.885K |
| NXP Semiconductors NV | NXPI | Sold | 2,621 | 2,325 | −296 | $ -75.114K |
| Bank of America Corp | BAC | Bought | 5,164 | 6,681 | +1,517 | $ 74.93K |
| Banco Bilbao Vizcaya Argentaria SA | BBVA | Bought | 20,161 | 23,088 | +2,927 | $ 74.798K |
| Gentex Corp | GNTX | Bought | 13,361 | 17,264 | +3,903 | $ 72.345K |
| AstraZeneca PLC | AZN | Sold | 3,578 | 3,215 | −363 | $ -66.616K |
| Medtronic PLC | MDT | Sold | 3,807 | 3,184 | −623 | $ -64.57K |
|
Vinci SA
|
VCISY | Bought | 16,835 | 18,781 | +1,946 | $ 61.133K |
|
BAE Systems PLC
|
BAESY | Bought | 5,373 | 5,983 | +610 | $ 60.154K |
|
Reckitt Benckiser Group PLC
|
RBGLY | Sold | 42,556 | 38,625 | −3,931 | $ -60.046K |
| Royal Bank of Canada | RY | Bought | 2,706 | 2,996 | +290 | $ 57.109K |
| CME Group Inc | CME | Sold | 1,222 | 1,046 | −176 | $ -55.526K |
| Coca-Cola Co/The | KO | Sold | 3,853 | 3,315 | −538 | $ -53.557K |
| Huntington Bancshares Inc/OH | HBAN | Bought | 18,138 | 21,451 | +3,313 | $ 50.967K |
| State Street Corp | STT | Bought | 1,696 | 1,976 | +280 | $ 46.761K |
|
Roche Holding AG
|
RHHBY | Sold | 10,464 | 9,711 | −753 | $ -45.749K |
| Citigroup Inc | C | Bought | 2,381 | 2,759 | +378 | $ 45.212K |
| Ambev SA | ABEV | Bought | 199,660 | 215,851 | +16,191 | $ 43.506K |
| GSK PLC | GSK | Bought | 11,080 | 11,910 | +830 | $ 41.117K |
| MSC Industrial Direct Co Inc | MSM | Bought | 2,478 | 2,822 | +344 | $ 40.227K |
| Marsh & McLennan Cos Inc | MRSH | Sold | 1,775 | 1,584 | −191 | $ -39.792K |
| McDonald's Corp | MCD | Sold | 1,330 | 1,187 | −143 | $ -39.756K |
| Procter & Gamble Co/The | PG | Sold | 2,131 | 1,902 | −229 | $ -39.732K |
|
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen
|
MURGY | Sold | 48,873 | 45,808 | −3,065 | $ -39.477K |
| Eastman Chemical Co | EMN | Bought | 4,628 | 5,227 | +599 | $ 37.817K |
| BXP Inc | BXP | Bought | 4,605 | 5,199 | +594 | $ 37.703K |
|
Siemens AG
|
SIEGY | Bought | 3,702 | 3,954 | +252 | $ 37.602K |
| LyondellBasell Industries NV | LYB | Bought | 9,017 | 9,628 | +611 | $ 36.807K |
|
Capgemini SE
|
CGEMY | Sold | 23,493 | 22,151 | −1,342 | $ -35.745K |
| UnitedHealth Group Inc | UNH | Bought | 741 | 829 | +88 | $ 33.969K |
| Sanofi SA | SNY | Sold | 12,988 | 12,312 | −676 | $ -32.394K |
| JPMORGAN CHASE & CO. | JPM | Bought | 904 | 997 | +93 | $ 30.782K |
| Tyson Foods Inc | TSN | Sold | 5,555 | 5,091 | −464 | $ -29.165K |
| Pfizer Inc | PFE | Sold | 12,549 | 11,540 | −1,009 | $ -28.854K |
| AbbVie Inc | ABBV | Sold | 1,216 | 1,122 | −94 | $ -27.647K |
|
AXA SA
|
AXAHY | Bought | 11,058 | 11,586 | +528 | $ 26.888K |
| United Parcel Service Inc | UPS | Bought | 2,738 | 2,966 | +228 | $ 25.367K |
| British American Tobacco PLC | BTI | Sold | 10,275 | 9,856 | −419 | $ -24.657K |
|
Publicis Groupe SA
|
PUBGY | Bought | 20,129 | 20,988 | +859 | $ 24.148K |
| Constellation Brands Inc | STZ | Sold | 2,424 | 2,272 | −152 | $ -22.077K |
| BP PLC | BP | Bought | 12,690 | 13,113 | +423 | $ 19.032K |
| Merck & Co Inc | MRK | Sold | 2,404 | 2,285 | −119 | $ -17.186K |
| Kraft Heinz Co/The | KHC | Bought | 12,323 | 12,986 | +663 | $ 16.848K |
| Chevron Corp | CVX | Sold | 1,588 | 1,520 | −68 | $ -14.763K |
| Novartis AG | NVS | Bought | 3,608 | 3,690 | +82 | $ 13.111K |
|
Nestle SA
|
NSRGY | Sold | 5,789 | 5,688 | −101 | $ -10.476K |
| Altria Group Inc | MO | Sold | 4,336 | 4,205 | −131 | $ -10.281K |
| Johnson & Johnson | JNJ | Sold | 1,208 | 1,174 | −34 | $ -9,557.07 |
| Dow Inc | DOW | Bought | 10,080 | 10,341 | +261 | $ 8,076.59 |
| Philip Morris International Inc | PM | Bought | 1,627 | 1,666 | +39 | $ 7,491.00 |
| Franklin Templeton Inc | BEN | Sold | 9,790 | 9,595 | −195 | $ -6,706.62 |
|
DHL AG
|
DHLGY | Bought | 17,607 | 17,752 | +145 | $ 4,819.18 |
| TotalEnergies SE | TTE | Bought | 6,482 | 6,534 | +52 | $ 4,695.44 |
| PepsiCo Inc | PEP | Sold | 2,319 | 2,294 | −25 | $ -3,596.34 |
| Lockheed Martin Corp | LMT | Bought | 551 | 557 | +6 | $ 3,554.76 |
| ExxonMobil Holdings Corp | XOM | Sold | 1,986 | 1,966 | −20 | $ -3,357.07 |
| Starbucks Corp | SBUX | Sold | 3,070 | 3,045 | −25 | $ -2,709.36 |
| Verizon Communications Inc | VZ | Sold | 7,096 | 7,088 | −8 | $ -372.46 |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up